Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Influenza A H5N6 Neuraminidase (NA), N-His

Cat. No.VG3F26

Product TypeVeterinary Antigens

Size

Product Overview

BioVenic's Recombinant Influenza A H5N6 Neuraminidase (NA), N-His is a recombinant protein expressed from E.coli Expression System. Its predicted molecular weight is 41.5 kDa. The purity is>90% (SDS-PAGE).

Specifications

Type Recombinant Protein
Species Virus
Expression System E.coli Expression System
Purity >90% (SDS-PAGE)
Predicted Molecular Weight 41.5 kDa
Physical State Lyophilized
Formulation PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Target Information

Neuraminidase is a critical surface glycoprotein of the highly pathogenic avian influenza (HPAI) H5N6 virus, a subtype noted for its significant impact on the poultry industry and zoonotic risk to humans. Functioning as a tetrameric enzyme, NA cleaves sialic acid residues from host cell receptors and viral glycoproteins. This activity is essential for the release of progeny virions from infected cells, preventing viral self-aggregation and facilitating spread. H5N6 NA is a primary target for antiviral drugs like oseltamivir and serves as a key marker for monitoring viral evolution and drug resistance.

Protein Influenza A H5N6 Neuraminidase (NA)
Protein Synonym NA; Sialidase; N6-NA; Exo-alpha-sialidase; Receptor-destroying enzyme
UniProt ID A0A0B4N5B2

Shipping and Storage

This product is shipped with gel ice bags. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.
Inquiry Basket